Yes, hepatocellular cancer does occur in primary biliary cirrhosis

被引:3
作者
Gores, GJ [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Med, Hepatobiliary Neoplasia Study Grp, Rochester, MN 55905 USA
关键词
D O I
10.1053/jlts.2002.0080570
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: The prevalence of hepatocellular carcinoma (HCC) in primary biliary cirrhosis (PBC) is not well established, as some reports suggest a low risk, whereas others indicate that HCC may be no less frequent than in other types of cirrhosis. Methods: We compared the incidence of HCC in a series of 140 patients with PBC (five men, 135 women, mean age 54 +/- 1.6 yr) followed-up for a mean of period of 5.6 +/- 0.4 yr with a group of patients with cirrhosis related to hepatitis C virus (HCV) who were matched for age, sex, and follow-up period. In all patients, HCC was prospectively screened by clinical, laboratory, and ultrasound procedures. Results: Five patients with PBC (3.6%) developed HCC. All were in stage IV of the disease. The incidence of HCC in the 45 patients with late stages of the disease (III or IV) was 11.1%, similar to that found in patients with HCV-related cirrhosis, which was 15.0%. The relative risk for HCC in late stages of PBC was of 0.812 (95% CI, 0.229-2.883) with respect to HCV-related cirrhosis. The probability for developing HCC was significantly higher in patients with HCV-related cirrhosis than in PBC patients overall (p = 0.001), but was similar in patients with HCV-related cirrhosis and in patients with PBC in stages III and IV (p = ns). Conclusion: The risk for HCC in patients with late stages of PBC is similar to that in patients with HCV-related cirrhosis.
引用
收藏
页码:570 / 571
页数:2
相关论文
共 6 条
[1]   Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference [J].
Bruix, J ;
Sherman, M ;
Llovet, JM ;
Beaugrand, M ;
Lencioni, R ;
Burroughs, AK ;
Christensen, E ;
Pagliaro, L ;
Colombo, M ;
Rodés, J .
JOURNAL OF HEPATOLOGY, 2001, 35 (03) :421-430
[2]  
Caballería L, 2001, AM J GASTROENTEROL, V96, P1160
[3]  
Jones DEJ, 1997, HEPATOLOGY, V26, P1138
[4]   The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells [J].
Libbrecht, L ;
Desmet, V ;
Van Damme, B ;
Roskams, T .
JOURNAL OF HEPATOLOGY, 2000, 33 (01) :76-84
[5]   Incidence of cancer in primary biliary cirrhosis: The Mayo experience [J].
Nijhawan, PK ;
Therneau, TM ;
Dickson, ER ;
Boynton, J ;
Lindor, KD .
HEPATOLOGY, 1999, 29 (05) :1396-1398
[6]   Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man [J].
Roskams, T ;
De Vos, R ;
Van Eyken, P ;
Myazaki, H ;
Van Damme, B ;
Desmet, V .
JOURNAL OF HEPATOLOGY, 1998, 29 (03) :455-463